Launch of Discovery Research Platform for Tissue Scale Biology
1 July 2024
Today (1 July 2024) marks the official start of the Discovery Research Platform for Tissue Scale Biology (DRP-TSB) at the Cambridge Stem Cell Institute. With funding from Wellcome, the platform will work over the next seven years to drive new waves of discovery and translational science into the ways stem cells build...
Celebrating the Institute and collaborators at the 2024 CSCI Annual Retreat
24 June 2024
This month, the Institute held the CSCI Annual Retreat on 6 and 7 June in Cambridge. This annual event brings together CSCI researchers, Affiliate Group Leaders, and our Stem Cells Interdisciplinary Research Centre members for a day and a half of talks, posters, Institute updates, and networking outside of the office and...
20 June 2024
Scientists in Cambridge and London have discovered novel immune responses that help explain how some individuals avoid getting COVID-19. Using single-cell sequencing, researchers from the Wellcome Sanger Institute, University College London (UCL) and Imperial College London (ICL), the Netherlands Cancer Institute and their...
11 June 2024
Epigenetic changes to DNA help explain differences in disease severity in patients Cambridge scientists from the Zilbauer Lab at Cambridge Stem Cell Institute (CSCI) have grown ‘mini-guts’ in the lab to help understand Crohn’s disease, showing that ‘switches’ that modify DNA in gut cells play an important role in the...